Abstract

Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating Type 1 regulatory T cells

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call